1. Home
  2. XOMA vs CLPT Comparison

XOMA vs CLPT Comparison

Compare XOMA & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • CLPT
  • Stock Information
  • Founded
  • XOMA 1981
  • CLPT 1998
  • Country
  • XOMA United States
  • CLPT United States
  • Employees
  • XOMA N/A
  • CLPT N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • CLPT Medical/Dental Instruments
  • Sector
  • XOMA Health Care
  • CLPT Health Care
  • Exchange
  • XOMA Nasdaq
  • CLPT Nasdaq
  • Market Cap
  • XOMA 330.2M
  • CLPT 338.0M
  • IPO Year
  • XOMA N/A
  • CLPT N/A
  • Fundamental
  • Price
  • XOMA $25.83
  • CLPT $11.23
  • Analyst Decision
  • XOMA Strong Buy
  • CLPT Strong Buy
  • Analyst Count
  • XOMA 2
  • CLPT 3
  • Target Price
  • XOMA $69.50
  • CLPT $27.67
  • AVG Volume (30 Days)
  • XOMA 59.0K
  • CLPT 572.1K
  • Earning Date
  • XOMA 08-12-2025
  • CLPT 08-06-2025
  • Dividend Yield
  • XOMA N/A
  • CLPT N/A
  • EPS Growth
  • XOMA N/A
  • CLPT N/A
  • EPS
  • XOMA N/A
  • CLPT N/A
  • Revenue
  • XOMA $42,909,000.00
  • CLPT $32,235,999.00
  • Revenue This Year
  • XOMA $70.91
  • CLPT $23.97
  • Revenue Next Year
  • XOMA $14.00
  • CLPT $27.52
  • P/E Ratio
  • XOMA N/A
  • CLPT N/A
  • Revenue Growth
  • XOMA 638.41
  • CLPT 23.22
  • 52 Week Low
  • XOMA $18.35
  • CLPT $6.25
  • 52 Week High
  • XOMA $35.00
  • CLPT $19.22
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 48.34
  • CLPT 44.91
  • Support Level
  • XOMA $25.42
  • CLPT $10.88
  • Resistance Level
  • XOMA $26.63
  • CLPT $11.64
  • Average True Range (ATR)
  • XOMA 0.89
  • CLPT 0.58
  • MACD
  • XOMA -0.19
  • CLPT 0.01
  • Stochastic Oscillator
  • XOMA 12.50
  • CLPT 26.58

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About CLPT ClearPoint Neuro Inc.

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.

Share on Social Networks: